US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Instil Bio, Inc.

16.92

+0.92005.75%

Volume:31.12K

Turnover:514.60K

Market Cap:110.42M

PE:-1.49

High:16.99

Open:16.41

Low:16.21

Close:16.00

Loading ...

Overview Company News Filings

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

My 3 Favorite Stocks to Buy Right Now

Private equity firms who hold 38% of Instil Bio, Inc. (NASDAQ:TIL) gained 34%, institutions profited as well

Simply Wall St.

EQT Reports Fourth Quarter and Full Year 2024 Results and Provides 2025 Guidance

Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025

High Growth Tech Stocks In The United States To Watch

Simply Wall St.

JMP Securities Keeps Their Hold Rating on Instil Bio (TIL)

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer

3 Stocks That Could Turn $1,000 Into $5,000 by 2030

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Instil Bio announces clinical progress in China for IMM2510/SYN-2510

Instil Bio Inc - Plans U.S. Trial of Syn-2510/Imm2510 in 2H 2025

THOMSON REUTERS

Instil Bio Inc - Initial Clinical Data From 1L Advanced Nsclc Trial in China Expected 2H 2025

THOMSON REUTERS

Instil Bio Announces Clinical Progress in China for Imm2510/Syn-2510, a Clinical-Stage Pd-L1xvegf Bispecific Antibody

THOMSON REUTERS

Instil Bio Announces Clinical Progress in China for IMM2510/SYN-2510, a Clinical-Stage PD-L1xVEGF Bispecific Antibody

Jefferies Upgrades Instil Bio to Buy From Hold, Adjusts Price Target to $52 From $11

MT Newswires Live

U.S. RESEARCH ROUNDUP-CNX Resources, Inari Medical, Royal Gold

Instil Bio Inc : Jefferies Raises to Buy From Hold

THOMSON REUTERS

Instil Bio upgraded to Buy from Hold at Jefferies

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/TIL/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TIL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TIL\",,,,,undefined,":{"symbol":"TIL","market":"US","secType":"STK","nameCN":"Instil Bio, Inc.","latestPrice":16.92,"timestamp":1745339096190,"preClose":16,"halted":0,"volume":31116,"delay":0,"floatShares":2669983,"shares":6525887,"eps":-11.39,"marketStatus":"Trading","change":0.92,"latestTime":"04-22 12:36:29 EDT","open":16.41,"high":16.99,"low":16.21,"amount":514600.017456,"amplitude":0.04875,"askPrice":17.16,"askSize":5,"bidPrice":16.9,"bidSize":9,"shortable":3,"etf":0,"ttmEps":-11.39,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745352000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1616126400000,"exchange":"NASDAQ","adjPreClose":16,"preHourTrading":{"tag":"盘前","latestPrice":15.2,"preClose":16,"latestTime":"08:33 EDT","volume":4,"amount":61.239996,"timestamp":1745325236914},"postHourTrading":{"tag":"盘后","latestPrice":16,"preClose":16,"latestTime":"16:05 EDT","volume":62,"amount":992,"timestamp":1745265913471},"volumeRatio":0.925496,"impliedVol":5.6162,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TIL\",,,,,undefined,":{"symbol":"TIL","floatShares":2669983,"roa":"-12.72%","roe":"-37.51%","lyrEps":-11.387623,"volumeRatio":0.925496,"shares":6525887,"dividePrice":0,"high":16.99,"amplitude":0.04875,"preClose":16,"low":16.21,"week52Low":9.62,"pbRate":"0.65","week52High":92,"institutionHeld":0,"latestPrice":16.92,"committee":0.285714,"eps":-11.39,"divideRate":0,"volume":31116,"delay":0,"ttmEps":-11.39,"open":16.41,"prevYearClose":19.09,"prevWeekClose":15.455,"prevMonthClose":17.36,"prevQuarterClose":17.36,"fiveDayClose":16.8,"twentyDayClose":19.51,"sixtyDayClose":23.435},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TIL\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2513928243","title":"Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2513928243","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513928243?lang=en_us&edition=fundamental","pubTime":"2025-02-22 06:15","pubTimestamp":1740176100,"startTime":"0","endTime":"0","summary":"SAN CARLOS, Calif., Feb. 21, 2025  -- Iovance Biotherapeutics, Inc.  , a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte  therapies for patients with cancer, today announced that on February 21, 2025 , the Company approved the grant of inducement stock options covering an aggregate of 328,730 shares of Iovance’s common stock to seventy-one new, non-executive employees.Iovance Biotherapeutics, Inc. aims to be the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte  therapies for patients with cancer. We are pioneering a transformational approach to cure cancer by harnessing the human immune system’s ability to recognize and destroy diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. Iovance’s Amtagvi is the first FDA-approved T cell therapy for a solid tumor indication. We are committed to continuous in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/iovance-biotherapeutics-reports-inducement-grants-221500860.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4505","PSQ","TQQQ","BK4112","QID","IE00BKPKM429.USD","IE00B3QW5Z07.USD","SQQQ","MNQmain","BK4588",".IXIC","LU2095319765.USD","BK4585","QLD","TIL","TSYW.SI","IE00BGHQF748.EUR","IE00B64PRP62.GBP","USJW.SI","BK4139","IOVA","LU2210150020.SGD","LU2210149790.SGD","NDAQ","USAW.SI","NVIW.SI","NQmain"],"gpt_icon":1},{"id":"2512579441","title":"My 3 Favorite Stocks to Buy Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2512579441","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512579441?lang=en_us&edition=fundamental","pubTime":"2025-02-20 19:30","pubTimestamp":1740051000,"startTime":"0","endTime":"0","summary":"The market's underestimating how well each of these companies should be able to capitalize on their opportunities.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/02/20/my-3-favorite-stocks-to-buy-right-now/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["GB00BDT5M118.USD","LU1988902786.USD","BK4230","IE00B7SZLL34.SGD","BK4139","IE00BZ199S13.USD","LU2087625088.SGD","SG9999015952.SGD","BK4535","TIL","LU1861214812.USD","LU0006306889.USD","SG9999014880.SGD","SG9999015978.USD","BK4505","LU0082616367.USD","SG9999018865.SGD","LU1861219969.SGD","BK4551","IE00B19Z3B42.SGD","SG9999015945.SGD","BK4585","SG9999014898.SGD","BK4503","SGXZ31699556.SGD","SG9999017495.SGD","UBER","LU1064131342.USD","IE0002270589.USD","LU0127658192.USD","LU1316542783.SGD","BK4536","LU0106261372.USD","SG9999018857.SGD","LU1983260115.SGD","SG9999014914.USD","LU1814569148.SGD","BK4588","LU2360107325.USD","LU0353189680.USD","SG9999015986.USD","IE00B19Z3581.USD","LU0642271901.SGD","BK4550","LU0353189763.USD","LU2264538146.SGD","SG9999014906.USD","LU0719512351.SGD","BK4022"],"gpt_icon":1},{"id":"2512417275","title":"Private equity firms who hold 38% of Instil Bio, Inc. (NASDAQ:TIL) gained 34%, institutions profited as well","url":"https://stock-news.laohu8.com/highlight/detail?id=2512417275","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512417275?lang=en_us&edition=fundamental","pubTime":"2025-02-20 18:11","pubTimestamp":1740046274,"startTime":"0","endTime":"0","summary":"Significant control over Instil Bio by private equity firms implies that the general public has more power to influence management and governance-related decisions. A look at the shareholders of Instil Bio, Inc.  can tell us which group is most powerful. With 38% stake, private equity firms possess the maximum shares in the company. In other words, the group stands to gain the most  from their investment into the company.While private equity firms were the group that reaped the most benefits after last week’s 34% price gain, institutions also received a 27% cut.Let's take a closer look to see what the different types of shareholders can tell us about Instil Bio.The definition of company insiders can be subjective and does vary between jurisdictions. Our data ref","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/private-equity-firms-hold-38-101114028.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["USJW.SI","BK4585","TIL","IE00B3QW5Z07.USD","QID","PSQ","NVIW.SI","NDAQ","LU2210150020.SGD","IE00B64PRP62.GBP","QLD","LU2210149790.SGD","NQmain","IE00BGHQF748.EUR","IE00BKPKM429.USD",".IXIC","TSYW.SI","BK4588","MNQmain","TQQQ","USAW.SI","BK4139","BK4112","BK4505","LU2095319765.USD","SQQQ"],"gpt_icon":1},{"id":"2512219051","title":"EQT Reports Fourth Quarter and Full Year 2024 Results and Provides 2025 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2512219051","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512219051?lang=en_us&edition=fundamental","pubTime":"2025-02-19 05:30","pubTimestamp":1739914200,"startTime":"0","endTime":"0","summary":"PITTSBURGH, Feb. 18, 2025 /PRNewswire/ --EQT Corporation  today announced financial and operational results for the fourth quarter and full year 2024 as well as financial and operational guidance for 2025.Sales volume of 605 Bcfe, at the high-end of guidance driven by continued operational efficiency gains and strong well performance, despite 27 Bcfe of total net curtailments. Differential $0.13 per Mcf tighter than mid-point of guidance as tactical curtailments maximize value without sacrificing operational efficiencies. Total per unit operating costs of $1.07 per Mcfe; at the low-end of guidance driven by production outperformance and lower-than expected LOE and SG&A expense. Projecting ~$2.6 billion and ~$3.3 billion of free cash flow attributable to EQT(1,2) in 2025 and 2026, respectively, at recent strip pricing. Expect to exit 2025 with ~$7 billion of net debt at recent strip pricing, well ahead of $7.5 billion debt target. President and CEO Toby Z. Rice stated, \"EQT's operations","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/eqt-reports-fourth-quarter-full-213000912.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eqt-reports-fourth-quarter-full-213000912.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","IE00B19Z3B42.SGD","IE0002270589.USD","LU1169589451.USD","LU1169590202.USD","BK4585","EQT","LU0006061336.USD","BK4505","ESG","IE00B19Z3581.USD","IE00B7SZLL34.SGD","BK4213","TIL","BK4588"],"gpt_icon":0},{"id":"2512192196","title":"Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2512192196","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512192196?lang=en_us&edition=fundamental","pubTime":"2025-02-19 05:01","pubTimestamp":1739912460,"startTime":"0","endTime":"0","summary":"SAN CARLOS, Calif., Feb.  18, 2025  (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/18/3028284/0/en/Iovance-Biotherapeutics-to-Report-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Corporate-Updates-on-February-27-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IOVA","TIL","BK4139","BK4505"],"gpt_icon":0},{"id":"2512692798","title":"High Growth Tech Stocks In The United States To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2512692798","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512692798?lang=en_us&edition=fundamental","pubTime":"2025-02-18 02:02","pubTimestamp":1739815326,"startTime":"0","endTime":"0","summary":"The United States market has shown a positive trajectory, climbing 1.5% in the past week and achieving a 22% increase over the last year, with earnings projected to grow by 15% annually in the coming years. In this favorable environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and robust financial health to capitalize on these expanding opportunities.Top 10 High Growth Tech Companies In The United States. Overview: Capricor Therapeutics, Inc. is a clinical-stage biotechnology company that develops cell and exosome-based therapeutics for treating Duchenne muscular dystrophy and other diseases with unmet medical needs, with a market cap of $725.25 million.Operations: Capricor Therapeutics focuses on developing cell and exosome-based therapeutics, primarily targeting Duchenne muscular dystrophy. The company generates revenue from its biotechnology segment, amounting to $23.23 million.Click here and access our complete","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/high-growth-tech-stocks-united-180206128.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TIL","UBCP","ARCT","BK4211","BK4139","CAPR","IOVA","BK4505"],"gpt_icon":0},{"id":"2511560319","title":"JMP Securities Keeps Their Hold Rating on Instil Bio (TIL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2511560319","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511560319?lang=en_us&edition=fundamental","pubTime":"2025-02-13 13:55","pubTimestamp":1739426121,"startTime":"0","endTime":"0","summary":"In a report released today, Reni Benjamin from JMP Securities maintained a Hold rating on Instil Bio (TIL – Research Report). The company’s shares ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jmp-securities-keeps-their-hold-rating-on-instil-bio-til?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jmp-securities-keeps-their-hold-rating-on-instil-bio-til?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TIL","JMP"],"gpt_icon":0},{"id":"2511153954","title":"Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2511153954","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511153954?lang=en_us&edition=fundamental","pubTime":"2025-02-13 06:30","pubTimestamp":1739399400,"startTime":"0","endTime":"0","summary":"SAN CARLOS, Calif., Feb.  12, 2025  (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (“Iovance” or the “Company”), a biotechnology company focused on innovating, developing, and delive","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/12/3025500/0/en/Iovance-Biotherapeutics-Reports-Inducement-Grants-under-NASDAQ-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","BK4139","MNQmain","SQQQ","BK4112",".IXIC","QID","TSYW.SI","BK4505","USJW.SI","BK4588","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","IOVA","NDAQ","QQQ","LU2095319765.USD","BK4585","NVIW.SI","LU2210149790.SGD","QLD","PSQ","TQQQ","LU2210150020.SGD","USAW.SI","IE00BGHQF748.EUR","TIL","NQmain"],"gpt_icon":0},{"id":"2510985579","title":"Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2510985579","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510985579?lang=en_us&edition=fundamental","pubTime":"2025-02-10 20:00","pubTimestamp":1739188800,"startTime":"0","endTime":"0","summary":"SAN CARLOS, Calif., Feb. 10, 2025  -- Iovance Biotherapeutics, Inc. , a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte  therapies for patients with cancer, today announced that Dan Kirby will join the Company’s executive leadership team in the newly created role of Chief Commercial Officer, effective today.Iovance Biotherapeutics, Inc. aims to be the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte  therapies for patients with cancer. We are pioneering a transformational approach to cure cancer by harnessing the human immune system’s ability to recognize and destroy diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. Iovance’s Amtagvi is the first FDA-approved T cell therapy for a solid tumor indication. We are committed to continuous innovation in cell therapy, includi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/iovance-biotherapeutics-appoints-dan-kirby-120000044.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BLDYK493.USD","TIL","BK4505","BK4139","KEX","LU1169589451.USD","IE00B64QTZ34.USD","LU1169590202.USD","IOVA","BK4021"],"gpt_icon":0},{"id":"2504943886","title":"3 Stocks That Could Turn $1,000 Into $5,000 by 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=2504943886","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504943886?lang=en_us&edition=fundamental","pubTime":"2025-01-19 06:50","pubTimestamp":1737240600,"startTime":"0","endTime":"0","summary":"A handful of bullish factors are converging at the right time in the right way for all three of these companies.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/01/18/3-stocks-that-could-turn-1000-into-5000-by-2030/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["CTV","BK4108","SGXZ23171101.USD","LU0882574139.USD","BK4524","LU0265550359.USD","IE00BKDWB100.SGD","LU1720051017.SGD","SG9999004303.SGD","LU2264538146.SGD","TIL","LU0642271901.SGD","LU0048584097.USD","LU2125154778.USD","ROKU","LU1720051108.HKD","IE0004445239.USD","LU0029864427.USD","LU1244550577.SGD","AMZN","LU0965509010.AUD","LU0323591593.USD","IE00B775H168.HKD","LU1880398554.USD","LU0096362180.USD","LU1814569148.SGD","IE00BFSS7M15.SGD","LU1914381329.SGD","LU0345768740.USD","LU0276348264.USD","LU0256863902.USD","LU0417517546.SGD","LU0256863811.USD","LU0957791311.USD","LU1861127337.USD","LU1778281490.HKD","LU0265550946.USD","IE000KEQY171.SGD","LU1935043536.SGD","SGXZ81514606.USD","SG9999015952.SGD","IE00B4JS1V06.HKD","LU0096364046.USD","USAW.SI","BK4554","IE0004091025.USD","BK4009","BK4585","LU1267930490.SGD","LU2092627202.USD"],"gpt_icon":1},{"id":"2504117139","title":"Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2504117139","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504117139?lang=en_us&edition=fundamental","pubTime":"2025-01-18 06:00","pubTimestamp":1737151200,"startTime":"0","endTime":"0","summary":"SAN CARLOS, Calif., Jan.  17, 2025  (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (\"Iovance\" or the “Company”), a biotechnology company focused on innovating, developing, and delive","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/17/3011722/0/en/Iovance-Biotherapeutics-Reports-Inducement-Grants-under-NASDAQ-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2095319765.USD","PSQ","BK4505","IE00B3QW5Z07.USD","TIL","BK4585","USAW.SI","QID","BK4112","LU2210149790.SGD","IOVA","NDAQ","TQQQ","TSYW.SI","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2210150020.SGD","NVIW.SI","BK4588","SQQQ","MNQmain","IE00B64PRP62.GBP",".IXIC","QLD","NQmain","USJW.SI"],"gpt_icon":1},{"id":"2503521416","title":"Instil Bio announces clinical progress in China for IMM2510/SYN-2510","url":"https://stock-news.laohu8.com/highlight/detail?id=2503521416","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503521416?lang=en_us&edition=fundamental","pubTime":"2025-01-14 20:10","pubTimestamp":1736856619,"startTime":"0","endTime":"0","summary":"Instil Bio (TIL)y announced clinical progress of IMM2510/SYN-2510 in China by its collaborator, ImmuneOnco Biopharmaceuticals. ImmuneOnco announced...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/instil-bio-announces-clinical-progress-in-china-for-imm2510-syn-2510?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/instil-bio-announces-clinical-progress-in-china-for-imm2510-syn-2510?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4505","TIL"],"gpt_icon":0},{"id":"2503839521","title":"Instil Bio Inc - Plans U.S. Trial of Syn-2510/Imm2510 in 2H 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2503839521","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503839521?lang=en_us&edition=fundamental","pubTime":"2025-01-14 20:00","pubTimestamp":1736856037,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250114:nTUAB2DZYX:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01541","TIL","BK4505","BK4139","BK1161"],"gpt_icon":0},{"id":"2503290715","title":"Instil Bio Inc - Initial Clinical Data From 1L Advanced Nsclc Trial in China Expected 2H 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2503290715","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503290715?lang=en_us&edition=fundamental","pubTime":"2025-01-14 20:00","pubTimestamp":1736856037,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250114:nTUAB2DZYX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK1161","BK4139","TIL","01541"],"gpt_icon":0},{"id":"2503252906","title":"Instil Bio Announces Clinical Progress in China for Imm2510/Syn-2510, a Clinical-Stage Pd-L1xvegf Bispecific Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=2503252906","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503252906?lang=en_us&edition=fundamental","pubTime":"2025-01-14 20:00","pubTimestamp":1736856037,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250114:nTUAB2DZYX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TIL","01541","BK4139","BK1161","BK4505"],"gpt_icon":0},{"id":"2503573521","title":"Instil Bio Announces Clinical Progress in China for IMM2510/SYN-2510, a Clinical-Stage PD-L1xVEGF Bispecific Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=2503573521","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503573521?lang=en_us&edition=fundamental","pubTime":"2025-01-14 20:00","pubTimestamp":1736856000,"startTime":"0","endTime":"0","summary":"ImmuneOnco announced dosing of first patient in its recently initiated Phase 1b/2 clinical trial of IMM2510/SYN-2510 in combination with chemotherapy in patients with advanced NSCLC in China ImmuneOnc","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/14/3009179/0/en/Instil-Bio-Announces-Clinical-Progress-in-China-for-IMM2510-SYN-2510-a-Clinical-Stage-PD-L1xVEGF-Bispecific-Antibody.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4552","BK4531","BK4563","LU0053666078.USD","BK4535","IE00BYTNYN87.SGD","IE00BYQNZ168.SGD","LU2039709279.SGD","LU1023057109.AUD","BK4526","BK4509","LU1169590202.USD","IE00B12V2V27.USD","LU0359202008.SGD","BK4548","PD","BK4571","LU1169589451.USD","BK4108","TIL","BK4585","TME","BK4588","01698","SSI","L","SG9999011746.SGD","BK4107","BK4023","LU0359201612.USD","BK4097","LU2065732104.USD","BK4565","PRGS"],"gpt_icon":0},{"id":"2501055207","title":"Jefferies Upgrades Instil Bio to Buy From Hold, Adjusts Price Target to $52 From $11","url":"https://stock-news.laohu8.com/highlight/detail?id=2501055207","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501055207?lang=en_us&edition=fundamental","pubTime":"2025-01-07 22:35","pubTimestamp":1736260528,"startTime":"0","endTime":"0","summary":"Price: 21.60, Change: +1.25, Percent Change: +6.14","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TIL"],"gpt_icon":0},{"id":"2501224384","title":"U.S. RESEARCH ROUNDUP-CNX Resources, Inari Medical, Royal Gold","url":"https://stock-news.laohu8.com/highlight/detail?id=2501224384","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501224384?lang=en_us&edition=fundamental","pubTime":"2025-01-07 16:32","pubTimestamp":1736238769,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-CNX Resources, Inari Medical, Royal GoldJan 7 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CNX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250107:nL4N3O30MD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261372.USD","NTRS","KEY","SCHW","SYF","DNLI","MTB","RF","AMG","LU2125154935.USD","WTFC","DFS","LU0098860793.USD","ATLC","FHI","OPRT","LU2430703095.HKD","CMA","ARQT","BLK","HAS","HBAN","TIL","CRMT","EE","BR","CFG","FITB","RGLD","PNC","CNX","NARI","KDP","TROW","ULTA","ALLY","LU0868494617.USD","FIZN","AXP","BAC","COF","STT","STZ","BEN","BK","LU1894683264.USD","USB","FDX","FCNCA"],"gpt_icon":1},{"id":"2501470932","title":"Instil Bio Inc : Jefferies Raises to Buy From Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2501470932","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501470932?lang=en_us&edition=fundamental","pubTime":"2025-01-07 14:45","pubTimestamp":1736232311,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250107:nFWN3O30B4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TIL","BK4505"],"gpt_icon":0},{"id":"2501300214","title":"Instil Bio upgraded to Buy from Hold at Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2501300214","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501300214?lang=en_us&edition=fundamental","pubTime":"2025-01-07 10:30","pubTimestamp":1736217021,"startTime":"0","endTime":"0","summary":"Jefferies upgraded Instil Bio (TIL) to Buy from Hold with a price target of $52, up from $11. Published first on TheFly – the ultimate source for r...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/instil-bio-upgraded-to-buy-from-hold-at-jefferies?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/instil-bio-upgraded-to-buy-from-hold-at-jefferies?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TIL"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":74,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TIL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-04","symbol":"TIL","fiscalQuarterEnding":"2024/12","expectedEps":-3.75,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741064400000,"reportTimeType":"pre","actualEps":-1.82},{"market":"US","date":"2024-11-13","symbol":"TIL","fiscalQuarterEnding":"2024/09","expectedEps":-2.08,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-3.54},{"market":"US","date":"2024-08-13","symbol":"TIL","fiscalQuarterEnding":"2024/06","expectedEps":-3.04,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-2.29},{"market":"US","date":"2024-05-10","symbol":"TIL","fiscalQuarterEnding":"2024/03","expectedEps":-2.16,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715313600000,"reportTimeType":"pre","actualEps":-3.74},{"market":"US","date":"2024-03-21","symbol":"TIL","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1710993600000,"reportTimeType":"post","actualEps":-1.99}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TIL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TIL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.25,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.25,"analysts":4,"updateTime":1736395200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TIL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TIL","date":"2025-04-21","current":-1.360458,"percent":0.558765,"low":-90.213566,"twenty":-17.408468,"median":-1.74944,"eighty":-0.374002,"high":-0.20845,"avg":-9.85757,"sd":17.220209,"marketCap":100857583},"quantilePoints":[{"date":"2021-03-19","current":-84.27082,"twenty":-76.060471,"median":-63.744947,"eighty":-63.744947,"marketCap":3180212216},{"date":"2021-03-26","current":-90.213566,"twenty":-88.546649,"median":-82.774855,"eighty":-70.558494,"marketCap":3404479566},{"date":"2021-04-01","current":-80.485142,"twenty":-88.066577,"median":-82.445731,"eighty":-80.543876,"marketCap":3037348273},{"date":"2021-04-09","current":-74.845406,"twenty":-86.731338,"median":-81.278889,"eighty":-75.844251,"marketCap":2824515933},{"date":"2021-04-16","current":-64.55119,"twenty":-84.152401,"median":-80.631978,"eighty":-68.532979,"marketCap":2436032807},{"date":"2021-04-23","current":-56.533253,"twenty":-83.665496,"median":-75.558867,"eighty":-63.744947,"marketCap":2133451889},{"date":"2021-04-30","current":-69.749259,"twenty":-83.442343,"median":-72.705025,"eighty":-62.947602,"marketCap":2632197554},{"date":"2021-05-07","current":-64.381318,"twenty":-82.464914,"median":-70.870412,"eighty":-62.947602,"marketCap":2429622194},{"date":"2021-05-14","current":-40.815404,"twenty":-81.185542,"median":-68.797979,"eighty":-59.923889,"marketCap":2317376214},{"date":"2021-05-21","current":-41.745089,"twenty":-80.805485,"median":-64.55119,"eighty":-56.641971,"marketCap":2370160894},{"date":"2021-05-28","current":-40.3619,"twenty":-80.72008,"median":-63.825313,"eighty":-44.35274,"marketCap":2291627589},{"date":"2021-06-04","current":-35.28265,"twenty":-80.485142,"median":-63.604479,"eighty":-40.88343,"marketCap":2003242993},{"date":"2021-06-11","current":-38.547882,"twenty":-76.985788,"median":-62.478757,"eighty":-39.182788,"marketCap":2188633091},{"date":"2021-06-18","current":-40.860755,"twenty":-75.558867,"median":-60.066581,"eighty":-39.182788,"marketCap":2319951076},{"date":"2021-06-25","current":-43.082927,"twenty":-74.845406,"median":-57.586456,"eighty":-39.454891,"marketCap":2446119337},{"date":"2021-07-02","current":-45.531851,"twenty":-74.539637,"median":-55.870754,"eighty":-40.135148,"marketCap":2585161909},{"date":"2021-07-09","current":-45.305099,"twenty":-72.202205,"median":-49.175495,"eighty":-40.243989,"marketCap":2572287597},{"date":"2021-07-16","current":-42.856175,"twenty":-71.45477,"median":-45.531851,"eighty":-40.34376,"marketCap":2433245024},{"date":"2021-07-23","current":-44.035286,"twenty":-70.97913,"median":-45.259749,"eighty":-40.507022,"marketCap":2500191448},{"date":"2021-07-30","current":-34.126213,"twenty":-69.97349,"median":-44.352739,"eighty":-39.999097,"marketCap":1937584001},{"date":"2021-08-06","current":-38.797309,"twenty":-69.667721,"median":-44.114649,"eighty":-38.86987,"marketCap":2202794834},{"date":"2021-08-13","current":-25.67905,"twenty":-68.288364,"median":-43.967261,"eighty":-38.248569,"marketCap":2128433760},{"date":"2021-08-20","current":-25.958677,"twenty":-65.584009,"median":-43.842547,"eighty":-37.250859,"marketCap":2151610897},{"date":"2021-08-27","current":-31.054096,"twenty":-64.639523,"median":-43.082927,"eighty":-36.865381,"marketCap":2573949841},{"date":"2021-09-03","current":-33.368784,"twenty":-64.415292,"median":-42.810824,"eighty":-36.162449,"marketCap":2765805032},{"date":"2021-09-10","current":-29.003501,"twenty":-64.095934,"median":-42.300631,"eighty":-35.128458,"marketCap":2403984168},{"date":"2021-09-17","current":-30.696796,"twenty":-63.809239,"median":-41.745089,"eighty":-33.823241,"marketCap":2544334610},{"date":"2021-09-24","current":-35.869889,"twenty":-63.744947,"median":-41.200883,"eighty":-33.058088,"marketCap":2973111647},{"date":"2021-10-01","current":-29.702568,"twenty":-63.576386,"median":-40.88343,"eighty":-32.244063,"marketCap":2461927011},{"date":"2021-10-08","current":-27.884994,"twenty":-63.076705,"median":-40.679353,"eighty":-30.911176,"marketCap":2311275620},{"date":"2021-10-15","current":-27.83839,"twenty":-62.614654,"median":-40.271199,"eighty":-30.162398,"marketCap":2307412764},{"date":"2021-10-22","current":-28.288899,"twenty":-61.744912,"median":-39.31884,"eighty":-29.292448,"marketCap":2344753707},{"date":"2021-10-29","current":-31.644419,"twenty":-60.684913,"median":-38.88801,"eighty":-29.292448,"marketCap":2622879353},{"date":"2021-11-05","current":-33.928037,"twenty":-60.019017,"median":-38.547882,"eighty":-29.457117,"marketCap":2812159306},{"date":"2021-11-12","current":-32.125999,"twenty":-59.054147,"median":-38.230429,"eighty":-29.609358,"marketCap":2662795533},{"date":"2021-11-19","current":-24.170578,"twenty":-57.966968,"median":-37.380108,"eighty":-29.087389,"marketCap":2867331542},{"date":"2021-11-26","current":-22.13825,"twenty":-57.38261,"median":-37.142018,"eighty":-28.403857,"marketCap":2626238467},{"date":"2021-12-03","current":-21.670923,"twenty":-56.859406,"median":-36.892591,"eighty":-28.164621,"marketCap":2570799953},{"date":"2021-12-10","current":-21.616583,"twenty":-56.003254,"median":-36.597813,"eighty":-28.071412,"marketCap":2564353614},{"date":"2021-12-17","current":-17.443246,"twenty":-54.107487,"median":-36.165051,"eighty":-27.857032,"marketCap":2069274786},{"date":"2021-12-23","current":-17.53019,"twenty":-51.143999,"median":-35.869889,"eighty":-27.625563,"marketCap":2079588929},{"date":"2021-12-31","current":-18.595261,"twenty":-45.822094,"median":-35.259974,"eighty":-26.135774,"marketCap":2205937171},{"date":"2022-01-07","current":-15.628279,"twenty":-45.531851,"median":-34.953335,"eighty":-25.306214,"marketCap":1853967067},{"date":"2022-01-14","current":-15.052271,"twenty":-45.500106,"median":-34.640367,"eighty":-24.382747,"marketCap":1785635875},{"date":"2022-01-21","current":-13.802444,"twenty":-45.373125,"median":-34.027125,"eighty":-24.170578,"marketCap":1637370080},{"date":"2022-01-28","current":-11.889664,"twenty":-45.305099,"median":-33.539667,"eighty":-23.692383,"marketCap":1410458951},{"date":"2022-02-04","current":-12.509144,"twenty":-45.214398,"median":-33.399854,"eighty":-22.768598,"marketCap":1483947214},{"date":"2022-02-11","current":-12.976471,"twenty":-45.169048,"median":-33.368784,"eighty":-21.583979,"marketCap":1539385729},{"date":"2022-02-18","current":-11.552754,"twenty":-44.352739,"median":-32.545439,"eighty":-20.008109,"marketCap":1370491650},{"date":"2022-02-25","current":-11.737511,"twenty":-44.262038,"median":-32.273579,"eighty":-18.836532,"marketCap":1392409202},{"date":"2022-03-04","current":-9.368273,"twenty":-44.203083,"median":-31.644419,"eighty":-18.169232,"marketCap":1111348826},{"date":"2022-03-11","current":-8.15329,"twenty":-44.067031,"median":-31.256049,"eighty":-17.512801,"marketCap":1278386950},{"date":"2022-03-18","current":-9.248631,"twenty":-43.999006,"median":-30.696796,"eighty":-16.712911,"marketCap":1450129843},{"date":"2022-03-25","current":-9.141568,"twenty":-43.971796,"median":-30.409402,"eighty":-15.543508,"marketCap":1433342944},{"date":"2022-04-01","current":-9.186537,"twenty":-43.91284,"median":-29.842381,"eighty":-14.704493,"marketCap":1440393806},{"date":"2022-04-08","current":-7.761182,"twenty":-43.881095,"median":-29.601591,"eighty":-13.798097,"marketCap":1216906695},{"date":"2022-04-14","current":-7.596401,"twenty":-43.835744,"median":-29.290895,"eighty":-13.43945,"marketCap":1191070035},{"date":"2022-04-22","current":-6.920799,"twenty":-43.631667,"median":-29.003501,"eighty":-12.8917,"marketCap":1085139728},{"date":"2022-04-29","current":-5.825006,"twenty":-43.255259,"median":-28.420946,"eighty":-12.630866,"marketCap":913325938},{"date":"2022-05-06","current":-5.371858,"twenty":-42.946876,"median":-28.288899,"eighty":-12.27222,"marketCap":842275122},{"date":"2022-05-13","current":-5.207077,"twenty":-42.842569,"median":-28.164621,"eighty":-11.707081,"marketCap":816438462},{"date":"2022-05-20","current":-5.001319,"twenty":-42.806289,"median":-28.118016,"eighty":-11.233233,"marketCap":939162598},{"date":"2022-05-27","current":-4.127636,"twenty":-42.502441,"median":-27.985971,"eighty":-10.409434,"marketCap":775099806},{"date":"2022-06-03","current":-4.134515,"twenty":-42.302899,"median":-27.861692,"eighty":-9.489052,"marketCap":776391639},{"date":"2022-06-10","current":-3.769907,"twenty":-42.280224,"median":-27.768483,"eighty":-9.159556,"marketCap":707924489},{"date":"2022-06-17","current":-3.219556,"twenty":-42.058007,"median":-27.411182,"eighty":-8.948853,"marketCap":604577848},{"date":"2022-06-24","current":-3.51537,"twenty":-41.717879,"median":-26.401419,"eighty":-8.77169,"marketCap":660126668},{"date":"2022-07-01","current":-3.267712,"twenty":-41.545546,"median":-25.632446,"eighty":-8.355887,"marketCap":613620679},{"date":"2022-07-08","current":-4.058842,"twenty":-41.291584,"median":-25.244075,"eighty":-8.136819,"marketCap":762181475},{"date":"2022-07-15","current":-4.024445,"twenty":-41.110182,"median":-24.894542,"eighty":-7.761182,"marketCap":755722310},{"date":"2022-07-22","current":-4.141394,"twenty":-40.951456,"median":-24.246655,"eighty":-7.357468,"marketCap":777683472},{"date":"2022-07-29","current":-3.879978,"twenty":-40.88343,"median":-24.121672,"eighty":-6.983828,"marketCap":728593817},{"date":"2022-08-05","current":-4.389053,"twenty":-40.860755,"median":-23.779328,"eighty":-6.706584,"marketCap":824189460},{"date":"2022-08-12","current":-4.26255,"twenty":-40.815404,"median":-23.464154,"eighty":-6.039221,"marketCap":901375864},{"date":"2022-08-19","current":-3.495904,"twenty":-40.543302,"median":-22.768598,"eighty":-5.668464,"marketCap":739257903},{"date":"2022-08-26","current":-3.140181,"twenty":-40.3619,"median":-21.643753,"eighty":-5.371858,"marketCap":664035169},{"date":"2022-09-02","current":-3.213779,"twenty":-40.271199,"median":-21.529638,"eighty":-5.09997,"marketCap":679598493},{"date":"2022-09-09","current":-3.845495,"twenty":-40.162358,"median":-20.975367,"eighty":-4.903683,"marketCap":813183693},{"date":"2022-09-16","current":-3.207646,"twenty":-39.590942,"median":-19.404931,"eighty":-4.657349,"marketCap":678301549},{"date":"2022-09-23","current":-2.992985,"twenty":-39.237209,"median":-18.801754,"eighty":-4.457242,"marketCap":632908520},{"date":"2022-09-30","current":-2.968452,"twenty":-39.037666,"median":-18.220312,"eighty":-4.364287,"marketCap":627720745},{"date":"2022-10-07","current":-3.029784,"twenty":-38.910685,"median":-17.975781,"eighty":-4.243271,"marketCap":640690182},{"date":"2022-10-14","current":-2.741525,"twenty":-38.815449,"median":-17.486718,"eighty":-4.140018,"marketCap":579733829},{"date":"2022-10-21","current":-2.753791,"twenty":-38.597767,"median":-16.975919,"eighty":-4.113877,"marketCap":582327716},{"date":"2022-10-28","current":-3.219912,"twenty":-38.547882,"median":-16.641725,"eighty":-4.080856,"marketCap":680895437},{"date":"2022-11-04","current":-1.551691,"twenty":-38.31206,"median":-15.606543,"eighty":-4.029948,"marketCap":328126753},{"date":"2022-11-11","current":-1.386095,"twenty":-38.234964,"median":-15.084875,"eighty":-3.950163,"marketCap":293109273},{"date":"2022-11-18","current":-0.964579,"twenty":-38.030887,"median":-14.574076,"eighty":-3.838633,"marketCap":216724411},{"date":"2022-11-25","current":-0.808629,"twenty":-37.695294,"median":-13.835048,"eighty":-3.794075,"marketCap":181685135},{"date":"2022-12-02","current":-0.72199,"twenty":-37.355165,"median":-13.742669,"eighty":-3.696738,"marketCap":162218871},{"date":"2022-12-09","current":-0.553102,"twenty":-37.241789,"median":-13.269908,"eighty":-3.527753,"marketCap":124272632},{"date":"2022-12-16","current":-0.333213,"twenty":-37.123878,"median":-12.911262,"eighty":-3.465238,"marketCap":74867253},{"date":"2022-12-23","current":-0.288738,"twenty":-37.037712,"median":-12.759109,"eighty":-3.399796,"marketCap":64874570},{"date":"2022-12-30","current":-0.363883,"twenty":-36.974222,"median":-12.639561,"eighty":-3.322747,"marketCap":81758311},{"date":"2023-01-06","current":-0.36602,"twenty":-36.865381,"median":-12.617824,"eighty":-3.267965,"marketCap":82238478},{"date":"2023-01-13","current":-0.450695,"twenty":-36.752004,"median":-12.259179,"eighty":-3.250578,"marketCap":101263508},{"date":"2023-01-20","current":-0.43897,"twenty":-36.733864,"median":-11.82989,"eighty":-3.219912,"marketCap":98629073},{"date":"2023-01-27","current":-0.471604,"twenty":-36.461761,"median":-11.661435,"eighty":-3.213779,"marketCap":105961366},{"date":"2023-02-03","current":-0.514172,"twenty":-36.189659,"median":-11.308222,"eighty":-3.164521,"marketCap":115525791},{"date":"2023-02-10","current":-0.46063,"twenty":-36.165051,"median":-11.107163,"eighty":-3.066583,"marketCap":103495639},{"date":"2023-02-17","current":-0.465539,"twenty":-36.053607,"median":-10.384437,"eighty":-2.992985,"marketCap":104598728},{"date":"2023-02-24","current":-0.440818,"twenty":-35.906633,"median":-9.736518,"eighty":-2.973358,"marketCap":99044354},{"date":"2023-03-03","current":-0.444746,"twenty":-35.857462,"median":-9.368273,"eighty":-2.900034,"marketCap":99926824},{"date":"2023-03-10","current":-0.368157,"twenty":-35.396991,"median":-9.164053,"eighty":-2.835976,"marketCap":82718646},{"date":"2023-03-17","current":-0.369659,"twenty":-35.246369,"median":-9.062951,"eighty":-2.751338,"marketCap":83056062},{"date":"2023-03-24","current":-0.344245,"twenty":-35.019617,"median":-8.88809,"eighty":-2.66302,"marketCap":77345957},{"date":"2023-03-31","current":-0.384248,"twenty":-34.955707,"median":-8.762728,"eighty":-1.622836,"marketCap":85755384},{"date":"2023-04-06","current":-0.38474,"twenty":-34.810795,"median":-8.705078,"eighty":-1.551691,"marketCap":85865211},{"date":"2023-04-14","current":-0.381943,"twenty":-34.715769,"median":-8.253816,"eighty":-1.408174,"marketCap":85240832},{"date":"2023-04-21","current":-0.379087,"twenty":-34.625287,"median":-8.136819,"eighty":-1.09858,"marketCap":84603444},{"date":"2023-04-28","current":-0.36335,"twenty":-34.301714,"median":-7.897985,"eighty":-0.886026,"marketCap":81091309},{"date":"2023-05-05","current":-0.379436,"twenty":-34.007307,"median":-7.678791,"eighty":-0.761266,"marketCap":84681492},{"date":"2023-05-12","current":-0.354811,"twenty":-33.85347,"median":-7.423381,"eighty":-0.704662,"marketCap":80232787},{"date":"2023-05-19","current":-0.343537,"twenty":-33.645304,"median":-7.313254,"eighty":-0.541435,"marketCap":77683236},{"date":"2023-05-26","current":-0.360909,"twenty":-33.539667,"median":-6.964672,"eighty":-0.508812,"marketCap":81611625},{"date":"2023-06-02","current":-0.328465,"twenty":-33.483742,"median":-6.920799,"eighty":-0.472667,"marketCap":74275164},{"date":"2023-06-09","current":-0.339395,"twenty":-33.399854,"median":-6.591237,"eighty":-0.462628,"marketCap":76746667},{"date":"2023-06-16","current":-0.31535,"twenty":-33.399854,"median":-6.109253,"eighty":-0.461208,"marketCap":71309360},{"date":"2023-06-23","current":-0.295504,"twenty":-33.39364,"median":-5.923875,"eighty":-0.456113,"marketCap":66821632},{"date":"2023-06-30","current":-0.319779,"twenty":-33.368784,"median":-5.740775,"eighty":-0.450811,"marketCap":72310970},{"date":"2023-07-07","current":-0.287623,"twenty":-33.294217,"median":-5.510394,"eighty":-0.448985,"marketCap":65039548},{"date":"2023-07-14","current":-0.348023,"twenty":-32.728749,"median":-5.371858,"eighty":-0.444746,"marketCap":78697853},{"date":"2023-07-21","current":-0.33997,"twenty":-32.517476,"median":-5.129869,"eighty":-0.440448,"marketCap":76876746},{"date":"2023-07-28","current":-0.313566,"twenty":-32.436695,"median":-5.001319,"eighty":-0.433933,"marketCap":70906115},{"date":"2023-08-04","current":-0.31023,"twenty":-32.185031,"median":-4.895421,"eighty":-0.404915,"marketCap":70151657},{"date":"2023-08-11","current":-0.294641,"twenty":-31.914725,"median":-4.730175,"eighty":-0.39128,"marketCap":66626513},{"date":"2023-08-18","current":-0.336613,"twenty":-31.687917,"median":-4.54747,"eighty":-0.386987,"marketCap":62542029},{"date":"2023-08-25","current":-0.333953,"twenty":-31.58228,"median":-4.458811,"eighty":-0.384195,"marketCap":62047729},{"date":"2023-09-01","current":-0.31582,"twenty":-31.479751,"median":-4.433769,"eighty":-0.383231,"marketCap":58678680},{"date":"2023-09-08","current":-0.308049,"twenty":-31.215658,"median":-4.327139,"eighty":-0.381873,"marketCap":57234802},{"date":"2023-09-15","current":-0.329122,"twenty":-31.035455,"median":-4.258344,"eighty":-0.380946,"marketCap":61150183},{"date":"2023-09-22","current":-0.296007,"twenty":-30.827288,"median":-4.224102,"eighty":-0.379063,"marketCap":54997442},{"date":"2023-09-29","current":-0.281444,"twenty":-30.678154,"median":-4.141394,"eighty":-0.374308,"marketCap":52291796},{"date":"2023-10-06","current":-0.277944,"twenty":-30.544554,"median":-4.129355,"eighty":-0.371172,"marketCap":51641401},{"date":"2023-10-13","current":-0.25561,"twenty":-30.398527,"median":-4.113877,"eighty":-0.368029,"marketCap":47491878},{"date":"2023-10-20","current":-0.262541,"twenty":-30.066082,"median":-4.089799,"eighty":-0.36446,"marketCap":48779661},{"date":"2023-10-27","current":-0.262541,"twenty":-29.87345,"median":-4.072601,"eighty":-0.363883,"marketCap":48779661},{"date":"2023-11-03","current":-0.269542,"twenty":-29.842381,"median":-4.045083,"eighty":-0.36335,"marketCap":50080452},{"date":"2023-11-10","current":-0.244969,"twenty":-29.702568,"median":-4.024445,"eighty":-0.360219,"marketCap":45514676},{"date":"2023-11-17","current":-0.221986,"twenty":-29.640428,"median":-3.96253,"eighty":-0.356595,"marketCap":43732592},{"date":"2023-11-24","current":-0.244304,"twenty":-29.578289,"median":-3.879978,"eighty":-0.354777,"marketCap":48129265},{"date":"2023-12-01","current":-0.223703,"twenty":-29.35148,"median":-3.82834,"eighty":-0.352625,"marketCap":44070798},{"date":"2023-12-08","current":-0.20845,"twenty":-29.286235,"median":-3.796429,"eighty":-0.347729,"marketCap":41065965},{"date":"2023-12-15","current":-0.214921,"twenty":-29.171277,"median":-3.776787,"eighty":-0.345147,"marketCap":42340740},{"date":"2023-12-22","current":-0.225816,"twenty":-29.031464,"median":-3.639199,"eighty":-0.344195,"marketCap":44487045},{"date":"2023-12-29","current":-0.252887,"twenty":-28.941362,"median":-3.559261,"eighty":-0.343247,"marketCap":49820287},{"date":"2024-01-05","current":-0.253547,"twenty":-28.848153,"median":-3.536008,"eighty":-0.33997,"marketCap":49950366},{"date":"2024-01-12","current":-0.243643,"twenty":-28.506387,"median":-3.483638,"eighty":-0.337429,"marketCap":47999180},{"date":"2024-01-19","current":-0.316934,"twenty":-28.369681,"median":-3.465238,"eighty":-0.336501,"marketCap":62437958},{"date":"2024-01-26","current":-0.386264,"twenty":-28.310648,"median":-3.452972,"eighty":-0.336501,"marketCap":76096261},{"date":"2024-02-02","current":-0.387914,"twenty":-28.292006,"median":-3.364023,"eighty":-0.336906,"marketCap":76421459},{"date":"2024-02-09","current":-0.384943,"twenty":-28.189477,"median":-3.322747,"eighty":-0.337071,"marketCap":75836103},{"date":"2024-02-16","current":-0.385428,"twenty":-28.164621,"median":-3.268344,"eighty":-0.337362,"marketCap":75931711},{"date":"2024-02-23","current":-0.388905,"twenty":-28.164621,"median":-3.262844,"eighty":-0.338574,"marketCap":76616578},{"date":"2024-03-01","current":-0.393527,"twenty":-28.145979,"median":-3.250578,"eighty":-0.339372,"marketCap":77527131},{"date":"2024-03-08","current":-0.384943,"twenty":-28.12423,"median":-3.219912,"eighty":-0.339395,"marketCap":75836103},{"date":"2024-03-15","current":-0.411684,"twenty":-28.071412,"median":-3.219556,"eighty":-0.33974,"marketCap":81104306},{"date":"2024-03-22","current":-0.490441,"twenty":-28.01238,"median":-3.210713,"eighty":-0.341385,"marketCap":76551538},{"date":"2024-03-28","current":-0.46252,"twenty":-27.987524,"median":-3.183762,"eighty":-0.342619,"marketCap":72193434},{"date":"2024-04-05","current":-0.452103,"twenty":-27.940919,"median":-3.140181,"eighty":-0.343247,"marketCap":70567456},{"date":"2024-04-12","current":-0.460854,"twenty":-27.866352,"median":-3.084982,"eighty":-0.343721,"marketCap":71933277},{"date":"2024-04-19","current":-0.433769,"twenty":-27.83839,"median":-3.023651,"eighty":-0.344096,"marketCap":67705734},{"date":"2024-04-26","current":-0.433353,"twenty":-27.810427,"median":-2.989918,"eighty":-0.344583,"marketCap":67640695},{"date":"2024-05-03","current":-0.467521,"twenty":-27.697023,"median":-2.974585,"eighty":-0.345113,"marketCap":72973903},{"date":"2024-05-10","current":-0.467937,"twenty":-27.564977,"median":-2.950052,"eighty":-0.345147,"marketCap":73038942},{"date":"2024-05-17","current":-0.622329,"twenty":-27.434484,"median":-2.896224,"eighty":-0.345147,"marketCap":76746173},{"date":"2024-05-24","current":-0.592794,"twenty":-27.114467,"median":-2.845789,"eighty":-0.345423,"marketCap":73103982},{"date":"2024-05-31","current":-0.582246,"twenty":-26.667064,"median":-2.818189,"eighty":-0.345841,"marketCap":71803199},{"date":"2024-06-07","current":-0.562886,"twenty":-25.902752,"median":-2.753791,"eighty":-0.345994,"marketCap":69415613},{"date":"2024-06-14","current":-0.553767,"twenty":-25.67905,"median":-2.723125,"eighty":-0.346555,"marketCap":68291086},{"date":"2024-06-21","current":-0.52265,"twenty":-25.641767,"median":-2.680193,"eighty":-0.347729,"marketCap":64453777},{"date":"2024-06-28","current":-0.52265,"twenty":-25.616911,"median":-2.594329,"eighty":-0.348771,"marketCap":64453777},{"date":"2024-07-05","current":-0.538994,"twenty":-25.554772,"median":-2.023945,"eighty":-0.351763,"marketCap":66469340},{"date":"2024-07-12","current":-0.511575,"twenty":-25.244075,"median":-1.60689,"eighty":-0.352331,"marketCap":63087956},{"date":"2024-07-15","current":-0.670849,"twenty":-25.225433,"median":-1.600756,"eighty":-0.352383,"marketCap":82729773},{"date":"2024-08-02","current":-0.656609,"twenty":-25.206792,"median":-1.576223,"eighty":-0.352434,"marketCap":80973716},{"date":"2024-08-09","current":-0.617582,"twenty":-25.070086,"median":-1.502626,"eighty":-0.352603,"marketCap":76160821},{"date":"2024-08-16","current":-0.555881,"twenty":-24.905416,"median":-1.404495,"eighty":-0.352625,"marketCap":66469990},{"date":"2024-08-23","current":-0.679893,"twenty":-24.611458,"median":-1.204279,"eighty":-0.352694,"marketCap":81298912},{"date":"2024-08-30","current":-0.682341,"twenty":-24.259697,"median":-1.002123,"eighty":-0.353381,"marketCap":81591588},{"date":"2024-09-06","current":-0.769639,"twenty":-24.235787,"median":-0.912595,"eighty":-0.354333,"marketCap":92030368},{"date":"2024-09-13","current":-2.527027,"twenty":-24.187968,"median":-0.964579,"eighty":-0.354673,"marketCap":302171797},{"date":"2024-09-20","current":-3.195498,"twenty":-24.151016,"median":-1.166962,"eighty":-0.355085,"marketCap":382104888},{"date":"2024-09-27","current":-3.7182,"twenty":-24.035815,"median":-1.218719,"eighty":-0.356243,"marketCap":444607492},{"date":"2024-10-04","current":-2.844673,"twenty":-23.866273,"median":-1.404495,"eighty":-0.356511,"marketCap":340154649},{"date":"2024-10-11","current":-2.039136,"twenty":-23.761939,"median":-1.502626,"eighty":-0.356632,"marketCap":243831698},{"date":"2024-10-18","current":-2.146287,"twenty":-23.668473,"median":-1.576223,"eighty":-0.356987,"marketCap":256644406},{"date":"2024-10-25","current":-1.679608,"twenty":-23.529363,"median":-1.613023,"eighty":-0.358234,"marketCap":200840833},{"date":"2024-10-31","current":-1.864539,"twenty":-23.355473,"median":-1.679608,"eighty":-0.359898,"marketCap":222954137},{"date":"2024-11-08","current":-1.546893,"twenty":-23.181584,"median":-1.612865,"eighty":-0.360219,"marketCap":184971285},{"date":"2024-11-15","current":-2.556005,"twenty":-22.768598,"median":-1.677433,"eighty":-0.360843,"marketCap":192122113},{"date":"2024-11-22","current":-2.149684,"twenty":-22.13825,"median":-1.702453,"eighty":-0.360909,"marketCap":161580962},{"date":"2024-11-29","current":-2.336348,"twenty":-21.764388,"median":-1.77289,"eighty":-0.362106,"marketCap":175611619},{"date":"2024-12-06","current":-2.273837,"twenty":-21.627451,"median":-1.829185,"eighty":-0.362787,"marketCap":170912980},{"date":"2024-12-13","current":-1.86057,"twenty":-21.5905,"median":-1.868075,"eighty":-0.363257,"marketCap":139849758},{"date":"2024-12-20","current":-1.743362,"twenty":-21.540506,"median":-1.87161,"eighty":-0.363514,"marketCap":131039810},{"date":"2024-12-27","current":-1.857966,"twenty":-21.281846,"median":-1.87161,"eighty":-0.363752,"marketCap":139653981},{"date":"2025-01-03","current":-1.877066,"twenty":-21.060138,"median":-1.864539,"eighty":-0.363883,"marketCap":141089676},{"date":"2025-01-10","current":-1.910058,"twenty":-20.781915,"median":-1.864539,"eighty":-0.363883,"marketCap":143569514},{"date":"2025-01-17","current":-1.859702,"twenty":-19.940727,"median":-1.858834,"eighty":-0.363909,"marketCap":139784499},{"date":"2025-01-24","current":-2.094986,"twenty":-19.671199,"median":-1.84885,"eighty":-0.364015,"marketCap":157469653},{"date":"2025-01-31","current":-2.084568,"twenty":-19.138664,"median":-1.86057,"eighty":-0.364757,"marketCap":156686546},{"date":"2025-02-07","current":-2.03508,"twenty":-18.845226,"median":-1.868075,"eighty":-0.365799,"marketCap":152966791},{"date":"2025-02-14","current":-2.070677,"twenty":-18.801754,"median":-1.86057,"eighty":-0.36602,"marketCap":155642404},{"date":"2025-02-21","current":-2.084568,"twenty":-18.63656,"median":-1.87161,"eighty":-0.367474,"marketCap":156686546},{"date":"2025-02-28","current":-1.677378,"twenty":-18.299649,"median":-1.862554,"eighty":-0.368093,"marketCap":126080136},{"date":"2025-03-07","current":-1.68924,"twenty":-18.217052,"median":-1.857966,"eighty":-0.369359,"marketCap":125231771},{"date":"2025-03-14","current":-1.677796,"twenty":-18.032295,"median":-1.827825,"eighty":-0.369974,"marketCap":124383406},{"date":"2025-03-21","current":-1.735014,"twenty":-17.977955,"median":-1.826465,"eighty":-0.370053,"marketCap":128625232},{"date":"2025-03-28","current":-1.704204,"twenty":-17.775808,"median":-1.812032,"eighty":-0.371545,"marketCap":126341172},{"date":"2025-04-04","current":-1.46389,"twenty":-17.569315,"median":-1.789377,"eighty":-0.372545,"marketCap":108525500},{"date":"2025-04-11","current":-1.248224,"twenty":-17.460635,"median":-1.76116,"eighty":-0.37304,"marketCap":92537077},{"date":"2025-04-17","current":-1.346814,"twenty":-17.417162,"median":-1.749709,"eighty":-0.373783,"marketCap":99846071},{"date":"2025-04-21","current":-1.360458,"twenty":-17.408468,"median":-1.74944,"eighty":-0.374002,"marketCap":100857583}],"updateTime":1745320379123}}}